Insider Holders & Insider Ownership - AMICUS THERAPEUTICS INC. (FOLD)

List of insiders holdings for AMICUS THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner		 2025-02-14 16:15:06 24,245,952
0		 24,245,952 Form 13G
2 Redmile Group LLC
Green Jeremy
10% Owner		 2025-02-14 20:00:35 14,184,495
0		 14,184,495 Form 13G
3 PERRY MARK W
10% Owner		 2012-03-09 15:52:38 0
4,584,311		 4,584,311 Form 4
4 NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
SANDELL SCOTT D
10% Owner		 2012-03-09 15:55:05 4,584,311
0		 4,584,311 Form 4
5 BARRIS PETER J
10% Owner		 2012-03-09 15:54:27 0
4,584,311		 4,584,311 Form 4
6 KRAMLICH C RICHARD
10% Owner		 2012-03-09 15:53:36 0
4,584,311		 4,584,311 Form 4
7 NEWHALL CHARLES W III
10% Owner		 2012-03-09 15:52:56 0
4,584,311		 4,584,311 Form 4
8 CHL Medical Partners II Side Fund L.P.
10% Owner		 2007-06-07 13:58:16 2,108,555
1,975,456		 4,084,011 Form 4
9 NEW ENTERPRISE ASSOCIATES 11 LP
NEA PARTNERS 11 LP
NEA 11 GP LLC
BARRETT M JAMES
BASKETT FOREST
DRANT RYAN D
KOLLURI KRISHNA KITTU
LINEHAN CHARLES M
SANDELL SCOTT D
TRAINOR III EUGENE A
10% Owner		 2007-06-07 20:28:23 3,659,157
0		 3,659,157 Form 4
10 Garden State Life Sciences Venture Fund L P
10% Owner		 2007-06-07 10:41:25 1,419,762
1,064,822		 2,484,584 Form 4
11 PROSPECT VENTURE PARTNERS II LP
PROSPECT ASSOCIATES II L P
PROSPECT MANAGEMENT CO II LLC
TANANBAUM JAMES B
SCHNELL DAVID
HIRSCH RUSSELL C
10% Owner		 2013-01-28 17:13:59 2,240,752
0		 2,240,752 Form 13G
12 QUAKER BIO VENTURES LP
10% Owner		 2012-02-14 14:33:03 1,429,762
0		 1,429,762 Form 13G
13 CHL Medical Partners II L.P.
10% Owner		 2010-02-05 14:33:55 1,365,941
0		 1,365,941 Form 13G
14 Campbell Bradley L
President and CEO		 2025-03-18 17:56:44 1,137,282
0		 1,137,282 Form 4
15 Crowley John F
Executive Chairman		 2024-03-15 19:14:06 927,013
0		 927,013 Form 4/A
16 Canaan Equity Partners III LLC
CANAAN EQUITY III LP
CANAAN EQUITY III ENTREPRENEURS LLC
BALEN JOHN V
GREEN L STEPHEN
DEEPAK KAMRA
KOPCHINSKY GREGORY
RUDNICK SETH
RUSSO GUY M
YOUNG ERIC A
10% Owner		 2010-02-10 16:10:48 552,191
0		 552,191 Form 13G
17 Rosenberg Ellen
Chief Legal Officer		 2025-02-13 17:00:13 507,710
15,000		 522,710 Form 4
18 Castelli Jeff
Chief Development Officer		 2025-02-13 17:19:31 465,476
0		 465,476 Form 4
19 Do Hung
Chief Science Officer		 2021-04-08 20:05:06 448,617
0		 448,617 Form 4
20 Quimi Daphne
Chief Financial Officer		 2023-01-19 18:16:09 398,532
0		 398,532 Form 4
21 Harford Simon N.R.
Chief Financial Officer		 2025-01-06 19:02:18 377,944
0		 377,944 Form 4
22 Clark David Michael
Chief People Officer		 2025-02-13 17:17:19 348,261
0		 348,261 Form 4
23 Barth Jay
Chief Medical Officer		 2020-10-02 16:34:33 177,870
20		 177,890 Form 4
24 Dilone Enrique
SVP, Technical Operations		 2015-06-23 20:09:25 158,598
0		 158,598 Form 4
25 LOVE TED W
Director		 2020-06-08 16:57:03 149,574
0		 149,574 Form 4
26 Baird William D III
Chief Financial Officer		 2018-10-17 18:28:05 141,622
0		 141,622 Form 4
27 WHITMAN BURKE W
Director		 2024-06-07 19:54:51 140,651
0		 140,651 Form 4
28 SBLENDORIO GLENN
Director		 2024-06-07 19:46:14 137,910
0		 137,910 Form 4
29 RAAB MICHAEL
Director		 2024-06-07 19:44:34 137,910
0		 137,910 Form 4
30 Bleil Lynn Dorsey
Director		 2024-06-07 19:49:26 135,994
0		 135,994 Form 4
31 Weinhoff Gregory M
Director		 2008-08-18 16:05:37 0
129,943		 129,943 Form 4
32 MCGLYNN MARGARET G
Director		 2024-06-07 19:41:47 113,603
0		 113,603 Form 4
33 Prout Samantha
Chief Accounting Officer		 2025-02-13 17:22:50 109,441
0		 109,441 Form 4
34 WHEELER CRAIG A
Director		 2024-06-07 19:53:32 106,684
0		 106,684 Form 4
35 Ludwig Karin
Senior VP, Clinical Research		 2007-05-30 19:56:54 106,667
0		 106,667 Form 3
36 Patterson Matthew R
Acting CEO & President		 2011-04-19 15:53:18 106,547
0		 106,547 Form 4
37 Lockhart David J
Chief Scientific Officer		 2013-06-20 16:10:15 100,000
0		 100,000 Form 4
38 Gershkowitz Jayne
SVP, Chief Patient Advocate		 2015-07-01 17:27:09 99,396
0		 99,396 Form 4
39 ROBERTS EIRY
Director		 2024-06-07 19:52:14 98,328
0		 98,328 Form 4
40 Kelly Michael Aaron
Director		 2024-06-07 19:47:57 94,521
0		 94,521 Form 4
41 Andrews Kurt J.
SVP, Human Resources		 2018-07-05 16:25:39 90,469
0		 90,469 Form 4
42 Boudes Pol F
Chief Medical Officer		 2012-06-06 16:44:04 80,000
0		 80,000 Form 4
43 Baldry Mark
VP Global Marketing		 2015-06-04 18:56:39 75,000
0		 75,000 Form 4
44 Valenzano Ken
SVP, Pharmacology & Biology		 2015-07-15 17:05:48 71,687
0		 71,687 Form 4
45 ESSNER ROBERT
Director		 2021-06-14 19:14:06 67,226
0		 67,226 Form 4
46 Peist Kenneth
VP, Legal & IP		 2016-01-06 16:18:25 63,874
0		 63,874 Form 4
47 Simon Mark
Sr. VP, Business Development		 2007-05-30 19:52:19 63,334
0		 63,334 Form 3
48 Bloch Stephen M
Director		 2009-02-12 13:31:12 0
61,700		 61,700 Form 4
49 David Allsop
SVP International		 2015-04-28 17:01:43 50,000
0		 50,000 Form 4
50 Kirk John
VP, Regulatory Affairs		 2015-06-03 19:18:58 45,000
0		 45,000 Form 4
51 Schaeffer Orlov S Nicole
SVP, HR & Leadership Devt		 2012-02-17 14:38:28 45,000
0		 45,000 Form 4
52 Branch Douglas A
VP, General Counsel & Sec.		 2007-05-30 19:47:28 40,002
0		 40,002 Form 3
53 Winterbottom Joan
SVP, Human Resources		 2013-06-20 16:11:11 40,000
0		 40,000 Form 4
54 Macaluso Peter M
VP & Corporate Counsel		 2013-06-20 16:12:21 35,000
0		 35,000 Form 4
55 Winkler Robert E
VP, Clin Research & Operations		 2012-06-06 16:48:12 35,000
0		 35,000 Form 4
56 Palling David
Sr VP, Technical Operations		 2009-06-30 12:53:51 34,040
0		 34,040 Form 4
57 Dentzer James E
Chief Financial Officer		 2009-10-01 13:49:13 32,075
0		 32,075 Form 4
58 Licholai Gregory P
VP, Medical Affairs		 2009-02-05 12:02:54 27,000
0		 27,000 Form 4
59 BARER SOL J
Director		 2016-06-13 14:37:44 20,000
0		 20,000 Form 4
60 Shenker Andrew
VP, Clinical Research		 2009-02-05 12:16:10 18,000
0		 18,000 Form 4
61 HAYDEN DONALD J JR
Director		 2018-06-11 16:44:59 17,807
0		 17,807 Form 4
62 John McAdam M
VP, Finance & Accounting		 2010-06-17 11:48:35 15,000
0		 15,000 Form 4
63 Topper James N
Director		 2014-06-16 12:50:45 15,000
0		 15,000 Form 4
64 BARRETT M JAMES
Director
10% Owner		 2014-06-16 11:35:16 15,000
0		 15,000 Form 4
65 Doshi Dipal
SVP Strategy & Bus Dev		 2015-07-09 18:26:35 14,206
0		 14,206 Form 4
66 BARKAS ALEXANDER E
Director		 2011-06-14 14:42:26 10,000
0		 10,000 Form 4
67 NEFF P SHERRILL
Director		 2010-06-17 09:52:54 10,000
0		 10,000 Form 4
68 Gilmore Geoffrey
SVP & General Counsel		 2012-03-13 13:28:06 10,000
0		 10,000 Form 4
69 GLAXOSMITHKLINE PLC
Former 10% Owner (1)		 2014-10-28 14:35:36 0
0		 0 Form 4
70 Yu Julie
VP Clinical Ops & Data Mgmt		 2015-06-16 20:14:59 0
0		 0 Form 4
71 FHM IV LP
Frazier Healthcare V LP
FHM V LP
FHM V LLC
FRAZIER HEALTHCARE IV LP
FRAZIER AFFILIATES IV LP
10% Owner		 2016-03-08 14:35:34 0
0		 0 Form 13G
72 Mount Sinai School of Medicine of New York University
10% Owner		 2007-06-07 15:44:37 0
0		 0 Form 4